Tamara Intermesoli
Bergamo, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Second attempt to discontinue TKI after molecular relapse in patients with chronic myeloid leukemia: A real-life Italian multicenter study.
Journal: Cancer
Published: November 16, 2025
Targetable Mutations in BRAF V600E-Negative Hairy-Cell Leukemia.
Journal: The New England journal of medicine
Published: April 11, 2025
Therapeutic Vaccinations with p210 Peptides in Imatinib-Treated Chronic Myeloid Leukemia Patients: 10 Years Follow-Up of GIMEMA CML0206 and SI0207 Studies.
Journal: Vaccines
Published: March 10, 2025
Clinical impact of tyrosine kinases related mutations in NPM1 mutated acute myeloid leukaemia: A report from the Northern Italy Leukaemia Group (NILG) multicentre randomized trial 02/06.
Journal: Leukemia research
Published: March 02, 2025
Direct determination of chronic myeloid leukemia prevalence in Lombardy-Italy: Global implications.
Journal: Hematological oncology
Published: August 09, 2024
Bosutinib Treatment of Chronic Myeloid Leukemia in Lombardy.
Journal: Acta haematologica
Published: April 28, 2024
Italian Physicians' Perceptions about the Role of Asciminib in Later Lines Chronic Myeloid Leukemia in Clinical Practice: A GIMEMA Survey.
Journal: Journal of clinical medicine
Published: July 18, 2023
Digital droplet PCR for T315I BCR::ABL1 KD mutation assessment in adult Ph-positive acute lymphoblastic leukemia with a minimal residual disease increase.
Journal: Leukemia & lymphoma
Published: July 15, 2023
Treatment-free remission in chronic myeloid leukemia patients treated front-line with nilotinib: 10-year followup of the GIMEMA CML 0307 study.
Journal: Haematologica
Published: October 13, 2021
COVID-19 infection in chronic myeloid leukaemia after one year of the pandemic in Italy. A Campus CML report.
Journal: British journal of haematology
Published: July 11, 2021
Last Updated: 09/26/2026